ERK inhibitor
CAS：896720-20-0
分子式：C24H20Cl2FN5O2
分子量：500.35
纯度：98%
存储：Store at -20°C

Background:

VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki< 2 nM.

VX-11e?is active in the HT29 cell proliferation assay (IC50=48 nM)[1].

VX-11e is orally bioavailable in both rat and mice[1]. VX-11e (50 mg/kg, p.o.) results in robust inhibition of pRSK, and inhibits tumor growth in NSG mice bearing human melanoma RPDX tumors. VX-11e with BKM120 significantly improves tumor growth inhibition[2].

参考文献:
[1]. Aronov, Alex M., et al. Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control. Journal of Medicinal Chemistry (2009), 52(20), 6362-6368.
[2]. Krepler C, et al. Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies. Clin Cancer Res. 2016 Apr 1;22(7):1592-602.